Associated Papers
Comparison of direct sequencing and Invader assay for Y93H mutation and response to interferon-free therapy in hepatitis C virus genotype 1b.
Hayashi K et al.
Journal of Gastroenterology and Hepatology, 2018
Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents.
Nitta S et al.
Scientific Reports, 2016
Successful achievement of sustained virological response to triple combination therapy containing simeprevir in two patients with chronic hepatitis C who had failed asunaprevir:Daclatasvir combination therapy.
Ozeki I et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology, 2016
Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1.
Kosaka K et al.
Journal of Viral Hepatitis, 2015
Update on hepatitis C virus resistance to direct-acting antiviral agents.
Poveda E et al.
Antiviral Research, 2014
Virological escape in HCV genotype-1-infected patients receiving daclatasvir plus ribavirin and peginterferon alfa-2a or alfa-2b.
McPhee F et al.
Antiviral Therapy, 2014
Ultradeep sequencing study of chronic hepatitis C virus genotype 1 infection in patients treated with daclatasvir, peginterferon, and ribavirin.
Murakami E et al.
Antimicrobial Agents and Chemotherapy, 2014
Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir.
McPhee F et al.
Hepatology (baltimore, Md.), 2013
Select a paper to view details